OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
Hannah A. Blair
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 255-265
Open Access | Times Cited: 28
Hannah A. Blair
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 255-265
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 2, pp. 465-473
Open Access | Times Cited: 11
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 2, pp. 465-473
Open Access | Times Cited: 11
Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives
Jan Versijpt, Koen Paemeleire, Uwe Reuter, et al.
The Lancet (2025) Vol. 405, Iss. 10483, pp. 1014-1026
Closed Access
Jan Versijpt, Koen Paemeleire, Uwe Reuter, et al.
The Lancet (2025) Vol. 405, Iss. 10483, pp. 1014-1026
Closed Access
New onset migraines after maxillary antrostomy for silent sinus syndrome treated with rimegepant: A rare case report
Aishwarya Aggarwal, Yasemin Akıncı, Brian L Gerhardstein
Brazilian Journal of Otorhinolaryngology (2025) Vol. 91, Iss. 4, pp. 101580-101580
Closed Access
Aishwarya Aggarwal, Yasemin Akıncı, Brian L Gerhardstein
Brazilian Journal of Otorhinolaryngology (2025) Vol. 91, Iss. 4, pp. 101580-101580
Closed Access
Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response
Gabriella Juhász, Kinga Gecse, Dániel Baksa
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108523-108523
Open Access | Times Cited: 10
Gabriella Juhász, Kinga Gecse, Dániel Baksa
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108523-108523
Open Access | Times Cited: 10
The effectiveness of agomelatine on headache severity and frequency in episodic migraine without aura; a parallel randomized controlled trial study
Kourosh Farzin, Azita Kheiltash, Abbas Tafakhori, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Kourosh Farzin, Azita Kheiltash, Abbas Tafakhori, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
David True, Kathleen Mullin, Robert Croop
Pain and Therapy (2024) Vol. 13, Iss. 5, pp. 1203-1218
Open Access | Times Cited: 3
David True, Kathleen Mullin, Robert Croop
Pain and Therapy (2024) Vol. 13, Iss. 5, pp. 1203-1218
Open Access | Times Cited: 3
Adverse events associated with Atogepant: a faers-based pharmacovigilance analysis
Ying Zhang, Shengzhu Sun, Y. Wang
Expert Opinion on Drug Safety (2024), pp. 1-7
Closed Access | Times Cited: 3
Ying Zhang, Shengzhu Sun, Y. Wang
Expert Opinion on Drug Safety (2024), pp. 1-7
Closed Access | Times Cited: 3
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine
William Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Expert Review of Neurotherapeutics (2024), pp. 1-11
Closed Access | Times Cited: 3
William Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Expert Review of Neurotherapeutics (2024), pp. 1-11
Closed Access | Times Cited: 3
Unlocking the potential of luteolin: A natural migraine management approach through network pharmacology
Rapuru Rushendran, Chitra Vellapandian
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 6, pp. 611-621
Open Access | Times Cited: 2
Rapuru Rushendran, Chitra Vellapandian
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 6, pp. 611-621
Open Access | Times Cited: 2
First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients
Yang Zhao, Xiaodan Wang, Mengyue Niu, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Yang Zhao, Xiaodan Wang, Mengyue Niu, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Neurasites®—A Standardized Plant Extract in the Treatment and Prevention of Migraine Attacks
Emilia Furdu Lunguţ, Claudia Antal, Suzana Turcu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3364-3364
Open Access | Times Cited: 1
Emilia Furdu Lunguţ, Claudia Antal, Suzana Turcu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3364-3364
Open Access | Times Cited: 1
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Jialing Hu, Jing-Ying Wu, Shan Xu, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Jialing Hu, Jing-Ying Wu, Shan Xu, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
CGRP Antagonism and Ketogenic Diet in the Treatment of Migraine
Francesca Finelli, Alessia Catalano, Michele De Lisa, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 163-163
Open Access
Francesca Finelli, Alessia Catalano, Michele De Lisa, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 163-163
Open Access
Rimegepant - a breakthrough drug for migraine treatment - literature review
Katarzyna Kuleta, Julia Głoskowska, Agata Frańczuk, et al.
Quality in Sport (2024) Vol. 19, pp. 54030-54030
Open Access
Katarzyna Kuleta, Julia Głoskowska, Agata Frańczuk, et al.
Quality in Sport (2024) Vol. 19, pp. 54030-54030
Open Access
Associations between the waist-to-height ratio index and migraine: A cross-section study of the NHANES 1999–2004
Jing Jin, Yafang Zheng, Tianqi Gao, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312321-e0312321
Open Access
Jing Jin, Yafang Zheng, Tianqi Gao, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312321-e0312321
Open Access
Efficient and Scalable Enantioselective Synthesis of a Key Intermediate for Rimegepant: An Oral CGRP Receptor Antagonist
Zhonghua Luo, Guodong Sun, Guowei Wang, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 01, pp. e62-e68
Open Access
Zhonghua Luo, Guodong Sun, Guowei Wang, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 01, pp. e62-e68
Open Access
O MANEJO DA CEFALEIA MIGRÂNEA COM AURA
Isabella Kaminski de Avellar, Lucas Oliveira Nepomuceno de Alcântara, Bernardo Augusto Taschetto de Mello, et al.
Revista Contemporânea (2024) Vol. 4, Iss. 5, pp. e4245-e4245
Open Access
Isabella Kaminski de Avellar, Lucas Oliveira Nepomuceno de Alcântara, Bernardo Augusto Taschetto de Mello, et al.
Revista Contemporânea (2024) Vol. 4, Iss. 5, pp. e4245-e4245
Open Access
Analyzing Google Search Trends for Migraine Surgery and Nurtec in Response to Public Announcements
Anthony E. Bishay, Arman Fijany, Cole Holan, et al.
Plastic & Reconstructive Surgery Global Open (2024) Vol. 12, Iss. 7, pp. e5996-e5996
Open Access
Anthony E. Bishay, Arman Fijany, Cole Holan, et al.
Plastic & Reconstructive Surgery Global Open (2024) Vol. 12, Iss. 7, pp. e5996-e5996
Open Access
Use of rimegepant as an alternative to triptans in migraine treatment
Aleksandra Jaroń, Katarzyna Jastrzębska, Maria Witkowska, et al.
Quality in Sport (2024) Vol. 18, pp. 53467-53467
Open Access
Aleksandra Jaroń, Katarzyna Jastrzębska, Maria Witkowska, et al.
Quality in Sport (2024) Vol. 18, pp. 53467-53467
Open Access
Role of calcitonin gene-related peptide (CGRP) receptor antagonist in acute and preventive treatment of migraine.
Michał Dacka, Mateusz Sobczyk, Paulina Dąbrowska, et al.
Prospects in Pharmaceutical Sciences (2024) Vol. 22, Iss. 3, pp. 21-26
Open Access
Michał Dacka, Mateusz Sobczyk, Paulina Dąbrowska, et al.
Prospects in Pharmaceutical Sciences (2024) Vol. 22, Iss. 3, pp. 21-26
Open Access
A real-world adverse events study of rimegepant from the FAERS database
Hong Pan, Shasha Lin
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access
Hong Pan, Shasha Lin
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access
Simple analgesics and combination oral products
Bradley D. Torphy
Elsevier eBooks (2024), pp. 211-223
Closed Access
Bradley D. Torphy
Elsevier eBooks (2024), pp. 211-223
Closed Access
Сучасні методи лікування та профілактики мігрені: використання моноклональних антитіл і гепантів
M. V. Shtroblia, A. L. Shtroblya, Г. В. Белик, et al.
Likarska sprava (2024), Iss. 3
Open Access
M. V. Shtroblia, A. L. Shtroblya, Г. В. Белик, et al.
Likarska sprava (2024), Iss. 3
Open Access
Gepants in the Acute Management of Migraine
William Wells-Gatnik, Paolo Martelletti
Pain Management (2023) Vol. 13, Iss. 11, pp. 627-630
Closed Access | Times Cited: 1
William Wells-Gatnik, Paolo Martelletti
Pain Management (2023) Vol. 13, Iss. 11, pp. 627-630
Closed Access | Times Cited: 1
